Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 18, Issue 1, 2013, Pages 78-86

  Adutler Lieber, Shimrit ^a,b   Ben Mordechai, Tammar ^a,b   Naftali Shani, Nili ^a,b   Asher, Elad ^b   Loberman, Dan ^b   Raanani, Ehud ^b   Leor, Jonathan ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

adipose tissue; heart; macrophages; mesenchymal stem cells

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADIPOSE TISSUE; ARTICLE; CELL GROWTH; CELL INTERACTION; CELL ISOLATION; CELL SHAPE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; HEART SURGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MESENCHYMAL STROMA CELL; MONOCYTE; MORPHOLOGY; PHAGOCYTOSIS; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASES; CELL COMMUNICATION; CELL POLARITY; CYTOKINES; HUMANS; MACROPHAGES; MESENCHYMAL STROMAL CELLS; MYOCYTES, CARDIAC; PHAGOCYTOSIS;

EID: 84871557132     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248412453875     Document Type: Article

References (34)

1. Stappenbeck TS, Miyoshi H. The role of stromal stem cells in tissue regeneration and wound repair. Science. 2009 ; 324 (5935). 1666-1669
2. Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther. 2010 ; 1 (2). 19
3. Dmitrieva RI, Minullina IR, Bilibina AA, Tarasova OV, Anisimov SV, Zaritskey AY. Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle. 2012 ; 11 (2). 377-383
4. Szoke K, Beckstrom KJ, Brinchmann JE. Human adipose tissue as a source of cells with angiogenic potential. Cell Transplant. 2012 ; 21 (1). 235-250
5. Acquistapace A, Bru T, Lesault PF, et al. Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells. 2011 ; 29 (5). 812-824
6. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011 ; 109 (8). 923-940
7. Amsalem Y, Mardor Y, Feinberg MS, et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation. 2007 ; 116 (11 suppl). I38 - I45
8. Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol. 2009 ; 37 (12). 1445-1453
9. Maggini J, Mirkin G, Bognanni I, et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010 ; 5 (2). e9252
10. Zhang QZ, Su WR, Shi SH, et al. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells. 2010 ; 28 (10). 1856-1868
11. Dayan V, Yannarelli G, Billia F, et al. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Res Cardiol. 2011 ; 106 (6). 1299-1310
12. Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009 ; 15 (1). 42-49
13. Mosser DM. The many faces of macrophage activation. J Leukoc Biol. 2003 ; 73 (2). 209-212
14. Laskin DL. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol. 2009 ; 22 (8). 1376-1385
15. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011 ; 473 (7347). 317-325
16. Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010 ; 121 (22). 2437-2445
17. Nahrendorf M, Swirski FK, Aikawa E, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007 ; 204 (12). 3037-3047
18. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol. 2009 ; 29 (10). 1419-1423
19. Vergadi E, Chang MS, Lee C, et al. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation. 2011 ; 123 (18). 1986-1995
20. Naftali-Shani N, Leor J, Asher E, et al. Human epicardial fat is a superior source for mesenchymal stromal cells with reparative and regenerative properties. Circulation. 2011 ;: 124
21. Itzhaki-Alfia A, Leor J, Raanani E, et al. Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation. 2009 ; 120 (25). 2559-2566
22. de Waal Malefyt R, Figdor CG, Huijbens R, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol. 1993 ; 151 (11). 6370-6381
23. Cassol E, Cassetta L, Rizzi C, Alfano M, Poli G. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J Immunol. 2009 ; 182 (10). 6237-6246
24. Ben-Mordechai T, Harel-Adar T, Holbova R, et al. Macrophage subpopulations are essential for infarct repair with and without stem cell therapy. Circulation. 2009 ; 120: S898 - S89S9
25. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008 ; 451 (7181). 937-942
26. Amsalem Y, Mardor Y, Feinberg MS, et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation. 2007 ; 116 (11 suppl). I38 - I45
27. Hirata Y, Tabata M, Kurobe H, et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol. 2011 ; 58 (3). 248-255
28. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest. 1995 ; 96 (5). 2304-2310
29. Han X, Kitamoto S, Wang H, Boisvert WA. Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice. FASEB J. 2010 ; 24 (8). 2869-2880
30. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res. 2009 ; 104 (2). e9 - e18
31. Roca H, Varsos ZS, Sud S, Craig MJ, Ying C, Pienta KJ. CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem. 2009 ; 284 (49). 34342-34354
32. Guerrero AR, Uchida K, Nakajima H, et al. Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation. 2012 ; 9: 40
33. Bunnell BA, Betancourt AM, Sullivan DE. New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther. 2010 ; 1 (5). 34
34. Anton K, Banerjee D, Glod J. Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion. PLoS One. 2012 ; 7 (4). e35036